Home/ Stocks/ TMCI

Treace Medical Concepts, Inc. Common Stock

TMCI XNAS

$2.01 +0.05 (+2.60%) ▲ 15-min delayed

Open

$2.11

High

$2.23

Low

$1.88

Volume

763.9K

Market Cap

$130.22M

About Treace Medical Concepts, Inc. Common Stock

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 450 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$212.69M	$-59,002,000	$-0.93
FY 2025	$212.69M	$-59,002,000	$-0.93
Q3 2025	$50.21M	$-16,288,000	$-0.26
Q2 2025	$47.39M	$-17,398,000	$-0.28

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for TMCI yet. Check out our latest market news or earnings calendar.

Get TMCI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Treace Medical Concepts, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.